Forman Mark S
SEC insider (Form 3/4/5 filer). CIK 0001922353. Chief Medical Officer at Ventyx Biosciences, Inc. (VTYX). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in SAN DIEGO, CA.
Companies Forman Mark S has filed insider reports for
- Ventyx Biosciences, Inc. (VTYX): Officer, Chief Medical Officer
Forman Mark S
CIK: 0001922353
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VTYX
Ventyx Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 4, 2026VTYX
Ventyx Biosciences, Inc.
DispositionDirect6K shares- - Nov 17, 2025VTYX
Ventyx Biosciences, Inc.
AwardDirect3K shares at avg. $1.03$3K - May 15, 2025VTYX
Ventyx Biosciences, Inc.
AwardDirect3K shares at avg. $1.03$3K - Jan 2, 2025VTYX
Ventyx Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
85K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | VTYX Ventyx Biosciences, Inc. | Disposition | 6,000 | - | $0 | Direct |
| Nov 17, 2025 | VTYX Ventyx Biosciences, Inc. | Award | 3,000 | $1.03 | $3,090 | Direct |
| May 15, 2025 | VTYX Ventyx Biosciences, Inc. | Award | 3,000 | $1.03 | $3,090 | Direct |
| Jan 2, 2025 | VTYX Ventyx Biosciences, Inc. | Award Stock Option (Right to Buy) | 85,000 | - | - | Direct |
1-4 of 4 transactions